Publications

Latest issue

Issue #2 2022

Challenges and opportunities: lessons learned in developing potential gene therapy…

While the full potential of gene therapies continues to be realised, their successes in rare diseases promote them as a…

By Dr Gaurav Shah (Rocket Pharmaceuticals)

Issue #2 2022

The promise of cell therapy: scaling up a new treatment…

Expectations are growing worldwide for discoveries that will harness the potential of cell therapy, which has already brought breakthroughs in…

By Dr Terri Gaskell (Rinri Therapeutics)

Issue #2 2022

Providing new hope for rare disease using non-viral gene therapy

Viral vectors to deliver gene therapies are utilised by clinically approved therapies. However, this method is not the only option…

By Brent Warner (Poseida Therapeutics)

Issue #2 2022

Antibody pipelines – the pharma perspective

Dr Erik Vernet, Director of Antibody Technology at Novo Nordisk, discusses antibody discovery and development workflows, including the role of…

By Dr Erik Vernet (Novo Nordisk)

Issue #2 2022

Miniaturising organoid drug screens using nanofibrillar cellulose hydrogels

Drug testing on advanced cell-based models such as organoids has gained in popularity, but significant technical hurdles remain that prevent…

By Dr Christian Stirnimann (ETH Zurich), Dr Tijmen Booij (ETH Zurich )

Issue #2 2022

Application note: Advancing CAR T-cell therapy with CTS TrueCut Cas9…

Read this free application note where we look at the CTS TrueCut Cas9 Protein, from its detailed quality specifications to…

By Thermo Fisher Scientific

Issue #2 2022

Chiral nanostructures could help accelerate drug discovery

A new photonic effect in semiconducting helical particles with nanoscale dimensions has been discovered by an international team of scientists…

By Professor Nicholas Kotov (University of Michigan), Professor Ventsislav Valev (University of Bath)

Issue #2 2022

Product hub: A reproducible and scalable Huntington’s disease human cell…

Senior scientist Dr Tony Oosterveen discusses bit.bio’s new ioDisease Model portfolio, including new models for Huntington’s disease to help advance…

By bit.bio

Bacteria Neisseria gonorrhoeae or Neisseria meningitidis, gonococcus and meningococcus

Issue #2 2022

A multi-step analysis including GCI reveals novel insight into LPS…

Antibiotic resistance is one of the key health challenges of the future. Researchers have carried out a multi-step analysis –…

By Dr Michael Hennig (leadXpro)

Scientist preparing samples for Cryo electron microscopy in liquid ethan under liquid nitrogen temperature.

Issue #2 2022

The promise of cryo-electron tomography

In this exclusive Q&A, Drug Target Review’s Ria Kakkad spoke with Dr Michael Grange, Tomography Group Leader from the Rosalind…

By Dr Michael Grange (RFI), Ria Kakkad (Drug Target Review)

Issue #2 2022

The bigger picture: innovation in microscopy

A broader view of cellular processes during the drug discovery and development stages enabled by microscopy could help scientists to…

By Dr Peter O'Toole (University of York), Victoria Rees (Drug Target Review)

Issue #2 2022

Using cortical spheroids to study endocannabinoids and autism spectrum disorder

The endocannabinoid system may play a role in the development of autism spectrum disorder and might be key to treating…

By Dr Karen Litwa (East Carolina University)

3d rendering of Cellular Therapy and Regeneration, microscope of cell, Embryonic stem cells background.

Issue #2 2022

New immune targets to improve survival from sepsis

In a pre-clinical study, researchers from the US set out to develop a treatment for sepsis. Here, Daniel Morales-Mantilla, Dr Robin Parihar…

By Daniel Morales-Mantilla (Baylor College of Medicine), Dr Katherine King (Baylor College of Medicine), Dr Robin Parihar (Baylor College of Medicine)

Issue #2 2022

Whole genome sequencing in cancer research

A recent whole genome sequencing study has revealed hidden insights into the causes of cancer. In an exclusive article, Dr Andrea Degasperi…

By Dr Andrea Degasperi (University of Cambridge), Ria Kakkad (Drug Target Review)

Issue #2 2022

Spatial biology is the next life science revolution

Dr Richard Goodwin, Head of Imaging & AI, Clinical Pharmacology & Safety Sciences at AstraZeneca, explores the latest innovation in…

By Dr Richard Goodwin (AstraZeneca)

Issue #3 2022

The next issue of Drug Target Review goes to press on 8 September 2022.

This issue will include In-Depth Focuses on: Antibodies, Assays, Next-Generation Sequencing and Synthetic Biology
Other articles will focus on CNS/Neuroscience, Organoids and Vaccine Development.

To receive our latest journal, you can secure your free print and/or digital copy here.

Past Issues

Issue #1 2022

Drug Target Review – Issue 1 2022

Issue #4 2021

Drug Target Review – Issue 4 2021

Issue #3 2021

Drug Target Review – Issue 3 2021

Issue #2 2021

Drug Target Review – Issue 2 2021

Issue #1 2021

Drug Target Review – Issue 1 2021

Issue #4 2020

Drug Target Review – Issue 4 2020

Issue #3 2020

Drug Target Review – Issue 3 2020

Issue #2 2020

Drug Target Review – Issue 2 2020

Issue #1 2020

Drug Target Review – Issue 1 2020

Issue #4 2019

Drug Target Review – Issue 4 2019

Issue #3 2019

Drug Target Review – Issue 3 2019

Issue #2 2019

Drug Target Review – Issue 2 2019

Issue #1 2019

Drug Target Review – Issue 1 2019

Issue #4 2018

Drug Target Review – Issue 4 2018

Issue #3 2018

Drug Target Review – Issue 3 2018

Supplements & Special Editions

Issue #1 2022

Drug Target Review Antibodies ebook 2022

Issue #1 2022

Drug Target Review Immuno-oncology ebook 2022

Issue #1 2022

Drug Target Review Assays ebook 2022

Issue #1 2022

Drug Target Review Vaccine Development ebook 2022

Issue #4 2021

Drug Target Review Flow Cytometry ebook 2021

Issue #4 2021

Drug Target Review Upstream Bioprocessing ebook 2021

Issue #3 2021

Drug Target Review Assays ebook 2021

Issue #3 2021

Drug Target Review Antibodies ebook 2021

Issue #3 2021

Drug Target Review Synthetic Biology ebook 2021

Issue #3 2021

Drug Target Review Vaccine Development ebook 2021

Issue #2 2021

Drug Target Review Stem Cells ebook 2021

Issue #2 2021

Drug Target Review Screening ebook 2021

Issue #2 2021

Drug Target Review Cell & Gene Therapy ebook 2021

Issue #2 2021

Drug Target Review Antibodies ebook 2021

Issue #1 2021

Cookie	Type	Duration	Description
cookielawinfo-checkbox-advertising-targeting	persistent	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	persistent	1 year	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	persistent	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	persistent	1 year	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	session	1 year	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	persistent	1 year	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	session	1 year	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Type	Duration	Description
advanced_ads_browser_width	persistent	1 month	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	persistent	2 years	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	persistent	1 month	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	persistent	1 year	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	persistent	2 years	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	persistent	2 years	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	persistent	3 months	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	persistent	1 month	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	persistent	5 months	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Cookie	Type	Duration	Description
bcookie	persistent	2 years	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	persistent	30 minutes	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	session	1 year	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	persistent	1 day	This cookie is set by LinkedIn and used for routing.
lissc	persistent	11 months	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	persistent	2 years	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	persistent	2 years	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	persistent	20 minutes	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	persistent	20 minutes	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	persistent	20 minutes	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	persistent	2 years	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	persistent	1 minute	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	persistent	1 day	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Type	Duration	Description
cf_ob_info	persistent	1 minute	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	persistent	1 minute	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	session	1 year	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	persistent	1 month	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	persistent	Until cleared	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	session	1 year	This cookie is set by Youtube and is used to track the views of embedded videos.

Recommended

Drug Target Review - Publications

Latest Issue

Latest issue

Next Issue

Past Issues

Past Issues

Supplements

Supplements & Special Editions